{"id":1148,"date":"2023-04-09T17:27:48","date_gmt":"2023-04-09T09:27:48","guid":{"rendered":"https:\/\/lumistarbiotech.com\/?page_id=1148"},"modified":"2023-10-19T02:18:10","modified_gmt":"2023-10-18T18:18:10","slug":"technology","status":"publish","type":"page","link":"https:\/\/legacy.lumistarbiotech.com\/ch\/technology\/","title":{"rendered":"Science-old"},"content":{"rendered":"
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

<\/p>\n

\n
\n

<\/p>\n

\n
\n
\n

Revolution<\/span><\/p>\n

\u00a0<\/div>\n

Induced Pluripotent Stem Cells (iPSC) Technology<\/h1>\n<\/div>\n<\/div>\n<\/div>\n

<\/p>\n

<\/p>\n

\n

<\/p>\n

\n

<\/p>\n

Induced pluripotent stem cell (iPSC) technology has the potential to transform the fields of drug discovery and cell therapy by providing a reliable source of human cells for research and therapeutic purposes.

iPSCs can be differentiated into a wide range of cell types, allowing researchers to study disease mechanisms and test potential drug candidates in a more physiologically relevant context. In addition, iPSCs can be used to generate organ-specific cells for use in cell therapies, which have the potential to treat a variety of diseases and conditions.<\/p>\n

<\/p>\n<\/div>\n

<\/p>\n<\/div>\n

<\/p>\n

<\/p>\n

\n

<\/p>\n

\n

<\/p>\n

\n

<\/p>\n

\u00a0<\/div>\n

<\/p>\n<\/div>\n

<\/p>\n

<\/p>\n

<\/p>\n

<\/p>\n

<\/p>\n

<\/p>\n

<\/p>\n<\/div>\n

<\/p>\n<\/div>\n

<\/p>\n<\/div>\n<\/div>\n

<\/p>\n

<\/p>\n

\n
\n

<\/p>\n

\n

Application of iPSC<\/h2>\n

iPSC are generated by reprogramming somatic cells, such as skin or blood cells, to an embryonic-like state through the forced expression of specific transcription factors. iPSCs have the capacity to differentiate into any cell type of the body,
allowing for the creation of patient\/organ-specific cells that can be used to study disease mechanisms and develop new therapies.<\/p>\n<\/div>\n

<\/p>\n

<\/p>\n

\n

<\/p>\n

\n
\n
\"\"<\/div>\n
\n

\u85e5\u7269\u958b\u767c<\/a><\/h3>\n<\/div>\n<\/div>\n<\/div>\n

<\/p>\n

<\/p>\n

\n
\n
\"\"<\/div>\n
\n

\u7d30\u80de\u6cbb\u7642<\/a><\/h3>\n<\/div>\n<\/div>\n<\/div>\n

<\/p>\n<\/div>\n

<\/p>\n<\/div>\n<\/div>\n

<\/p>\n

<\/p>\n

\n
\n

<\/p>\n

\n

<\/p>\n

\n
\n
\n

Application of iPSC<\/span><\/p>\n

\u00a0<\/div>\n

\u85e5\u7269\u958b\u767c<\/h2>\n<\/div>\n

iPSC-derived cells can be used to create disease models by restoring disease phenotypes, either from patient samples or by CRISPR editing. Researchers can generate iPSCs from patients with specific genetic mutations or disease phenotypes, and differentiate these cells into relevant cell types such as cardiomyocytes, neurons, or liver cells. These cells are then used to study disease mechanisms, screen large libraries of compounds or drugs, and identify potential therapeutics that can restore normal function or alleviate disease symptoms.<\/p>\n<\/div>\n<\/div>\n

<\/p>\n

<\/p>\n

\n

Available Disease Models in LumiSTAR<\/h4>\n<\/div>\n

<\/p>\n

<\/p>\n